NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
29 hedge funds and large institutions have $706K invested in Navidea Biopharmaceuticals Inc. in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $772K → $706K (-$66.4K)
Holders
29
Holding in Top 10
–
Calls
$60K
Puts
$16K
Top Buyers
| 1 | +$151K | |
| 2 | +$148K | |
| 3 | +$21K | |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$14K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$4K |
Top Sellers
| 1 | -$38K | |
| 2 | -$4.58K | |
| 3 | -$2.63K | |
| 4 |
Morgan Stanley
New York
|
-$77 |